How Much Does CJC-1295 No DAC Cost 2026? — Pricing Breakdown
CJC-1295 no DAC costs $35–$85 per 2mg vial in 2026, with pricing driven primarily by purity verification, batch size, supplier certification, and COA transparency. The $50 difference between the low and high ends isn't arbitrary. It reflects third-party testing frequency, storage handling, and the presence of actual certificate-of-analysis documentation beyond marketing claims.
Our team has guided hundreds of research facilities through peptide procurement decisions. The gap between a reliable research-grade source and one that looks legitimate on paper comes down to three things most guides never mention: batch traceability, lyophilisation quality, and the difference between claimed purity and verified purity.
How much does CJC-1295 no DAC cost per research cycle in 2026?
For a standard 8-week research protocol using 100mcg dosing three times weekly, expect to budget $70–$140 for peptide costs. Covering 2–4 vials at 2mg each depending on reconstitution volume and injection precision. This calculation assumes minimal waste during reconstitution and accurate dosing with insulin syringes. Labs using prefilled syringes or higher dosing frequencies (daily protocols) should budget toward the upper range.
CJC-1295 No DAC Pricing Isn't About the Peptide Alone
The sticker price tells you almost nothing about total research cost. A $45 vial becomes a $60 investment once you factor in bacteriostatic water ($8–$12 per 30mL), alcohol prep pads, insulin syringes (approximately $0.20 each for 100-unit 0.5mL syringes), and cold storage handling. Labs ordering peptides without accounting for reconstitution supplies and storage infrastructure consistently underestimate per-protocol costs by 25–35%.
CJC-1295 without DAC (Drug Affinity Complex) differs structurally from the DAC variant through the absence of the lysine linker that extends half-life to 6–8 days. The no DAC form has a half-life of approximately 30 minutes post-injection, requiring more frequent dosing but allowing precise control over growth hormone secretion patterns. This structural difference doesn't affect raw synthesis cost. Both variants cost similar amounts to produce. But it does affect research design and total peptide consumption across protocols.
Purity verification is where cost divergence begins. A supplier charging $35 per vial typically provides batch-level purity claims without third-party HPLC verification. A $75 supplier includes COA documentation from independent labs showing peptide content at 98%+ with contaminant screening. The peptide molecule is identical. What you're paying for is the paper trail proving it. Research facilities operating under institutional review boards or publishing data cannot use peptides without verified purity documentation, which immediately eliminates the lower price tier regardless of actual quality.
The Hidden Variables That Control CJC-1295 No DAC Cost
Batch size matters more than most labs realise. Peptide synthesis cost per milligram drops sharply after 10-gram production runs. The fixed costs of column setup, solvent prep, and quality control get distributed across more product. Suppliers producing 50+ grams per synthesis cycle can offer pricing 30–40% lower than those running 5-gram batches. This is why bulk buyers securing 20+ vials at once see per-unit costs drop to $28–$32 range. They're accessing the wholesale tier that small-volume purchasers never see.
Lyophilisation quality determines shelf stability and reconstitution reliability. Peptides freeze-dried under suboptimal vacuum pressure or incomplete moisture removal degrade faster during storage and may not fully dissolve during reconstitution. A properly lyophilised 2mg vial stored at −20°C maintains 95%+ potency for 24 months; poorly processed vials lose 15–20% potency within 6 months even under ideal conditions. The $15 price premium for verified lyophilisation standards is invisible until you're three months into a protocol and observing reduced response consistency.
Storage and shipping infrastructure isn't reflected in listed pricing but determines whether the peptide arriving at your facility matches the COA. CJC-1295 no DAC requires storage at −20°C; any temperature excursion above −10°C during transit causes partial degradation that neither visual inspection nor weight verification can detect. Suppliers using cold-chain logistics with real-time temperature monitoring charge $8–$15 more per order than those shipping with standard ice packs. But the former guarantees peptide integrity on arrival while the latter leaves it to chance.
2026 CJC-1295 No DAC Pricing: Commercial vs Research-Grade Comparison
Budget Commercial
$28–$38
Claimed 95%+ (no COA)
Periodic (unspecified)
Standard shipping, no cold chain
Minimal or none
Suitable only for preliminary in-vitro work where purity documentation isn't required. Institutional research should avoid this tier entirely
Mid-Tier Research
$45–$65
Third-party HPLC COA provided
Every 3–5 batches
Temperature-monitored shipping, inconsistent cold storage
Basic reconstitution guide included
Acceptable for most academic and industry research where COA suffices and publication isn't anticipated. Represents best value-to-verification ratio for non-critical protocols
Premium Certified
$70–$90
Full third-party HPLC, MS, and endotoxin screening per batch
Every batch
Cold-chain logistics with continuous monitoring, guaranteed −20°C storage
Detailed protocol support and consultation
Required for clinical research, IRB-governed studies, and any work intended for peer-reviewed publication. The premium reflects traceability standards and liability coverage
Key Takeaways
CJC-1295 no DAC costs $35–$85 per 2mg vial in 2026, with price variation driven by purity documentation, batch testing frequency, and cold-chain logistics rather than peptide quality alone.
An 8-week research protocol at standard dosing (100mcg three times weekly) requires 2–4 vials, bringing total peptide cost to $70–$140 before accounting for reconstitution supplies and storage.
The no DAC form has a 30-minute half-life compared to 6–8 days for the DAC variant, requiring more frequent dosing but offering precise control over growth hormone pulse patterns.
Budget-tier suppliers ($28–$38 per vial) typically lack third-party COA documentation, making them unsuitable for institutional research or any protocol requiring verified purity.
Bulk purchasing (20+ vials) can reduce per-unit cost to $28–$32 by accessing wholesale pricing tiers unavailable to small-volume buyers.
Cold-chain shipping adds $8–$15 per order but prevents temperature-induced degradation that standard ice-pack shipping cannot guarantee.
What If: CJC-1295 No DAC Cost 2026 Scenarios
What If I Find CJC-1295 No DAC Priced Below $30 Per Vial?
Verify the supplier provides third-party COA documentation before ordering. Pricing below $30 per 2mg vial typically indicates either bulk wholesale access, clearance of older stock approaching expiration, or absence of purity verification. Request batch-specific HPLC results showing peptide content above 97%. If the supplier cannot provide this within 24 hours, the low price reflects unverified quality. Labs publishing research or operating under institutional oversight cannot use peptides without COA regardless of price.
What If My Research Protocol Requires Daily Dosing Instead of Three Times Weekly?
Budget for 6–8 vials per 8-week cycle instead of 2–4. Daily dosing at 100mcg consumes approximately 5.6mg total across 8 weeks (56 doses × 100mcg), requiring three 2mg vials minimum with a fourth vial accounting for reconstitution waste and dosing precision margin. This shifts per-protocol peptide cost from $70–$140 to $180–$280 range before supplies. Daily protocols are common when mimicking natural growth hormone pulsatility patterns. The increased peptide consumption is a protocol design cost, not a sourcing inefficiency.
What If I Need to Store Reconstituted CJC-1295 No DAC for More Than Two Weeks?
Reconstituted CJC-1295 no DAC maintains 90%+ potency for 28 days when refrigerated at 2–8°C in bacteriostatic water. Beyond 28 days, degradation accelerates regardless of storage conditions. Bacterial growth inhibition remains effective, but peptide bond hydrolysis reduces active compound concentration by 10–15% per additional week. Labs running protocols longer than 4 weeks should plan reconstitution in stages: mix only what you'll use within 28 days, keeping remaining vials in lyophilised form at −20°C until needed. The cost of replacing partially degraded peptide exceeds the minor inconvenience of staged reconstitution.
The Blunt Truth About CJC-1295 No DAC Pricing
Here's the honest answer: most peptide pricing is theatre. The actual synthesis cost for CJC-1295 no DAC is $8–$12 per 2mg vial at commercial scale. Everything above that is markup, testing overhead, logistics, and liability coverage. A supplier charging $85 isn't producing a fundamentally different peptide than one charging $45. They're producing identical documentation standards and accepting higher operational costs to meet institutional requirements. The peptide works the same either way if purity is equivalent. What you're buying at the premium tier isn't better CJC-1295. It's better paperwork and guaranteed cold chain. For independent research without publication intent, mid-tier sourcing at $45–$55 delivers identical biological activity at half the cost. For institutional work, the premium tier isn't optional regardless of budget constraints. Compliance requires it.
Our experience guiding research procurement decisions has shown that protocol failures trace back to storage and reconstitution errors three times more often than peptide purity issues. A $35 vial handled correctly outperforms an $85 vial left at room temperature for six hours during shipping. The cost hierarchy exists because institutions need liability protection and audit trails, not because expensive peptides work better in the lab.
How Reconstitution and Storage Standards Affect Real Research Cost
The listed price per vial captures only the peptide itself. Real Peptides structures pricing to reflect the full research investment: peptide cost, bacteriostatic water, sterile handling supplies, and the knowledge infrastructure to use them correctly. We've found that labs purchasing peptides without accounting for these auxiliary costs consistently run 20–30% over budget by their second protocol cycle. A 2mg vial of CJC-1295 no DAC at $58 becomes a $73 research input once you add bacteriostatic water ($10 per 30mL bottle sufficient for 10–12 reconstitutions), alcohol prep pads ($8 per 100-count box), and insulin syringes ($6 per 10-pack of 0.5mL 29-gauge).
Reconstitution volume determines how many doses you extract per vial. Standard practice uses 2mL bacteriostatic water per 2mg vial, creating a 1mg/mL solution where 0.1mL (10 units on an insulin syringe) delivers 100mcg. Labs using 1mL reconstitution volume double the concentration to 2mg/mL, reducing injection volume but increasing dosing precision requirements. A 5-unit error at 2mg/mL represents 10mcg variance versus 5mcg at 1mg/mL. Higher concentration reconstitution marginally reduces bacteriostatic water cost but raises the stakes for measurement accuracy.
Waste during reconstitution and injection typically consumes 5–10% of peptide volume. Drawing solution from a vial leaves approximately 0.05–0.1mL unrecoverable in the vial and needle hub. Over a full protocol, this compounds to one additional vial needed per 10–12 used. Labs ordering peptides should budget 10% above calculated needs to account for this structural waste. Attempting to recover every last microgram by overfilling syringes or reusing reconstitution vials introduces contamination risk that far exceeds the $5–$7 cost of an extra vial.
Cold storage infrastructure is the hidden fixed cost most budgets ignore. A laboratory-grade refrigerator maintaining 2–8°C costs $400–$1,200; a −20°C freezer rated for biological storage runs $600–$2,500. Labs without existing cold storage often use standard residential freezers, which cycle between −15°C and −22°C and allow temperature spikes during defrost cycles. This compromises lyophilised peptide stability over months. Peptide suppliers don't include cold storage in per-vial pricing because it's infrastructure, not consumable cost. But it's non-negotiable for maintaining peptide integrity across multi-month storage.
From peptide selection through protocol completion, cost per vial tells you less than cost per research outcome. A $45 peptide that degrades during storage delivers worse per-dollar results than a $75 peptide with verified stability. Our team's recommendation: budget for mid-tier sourcing with full COA documentation, invest in proper cold storage once rather than replacing degraded peptides repeatedly, and calculate total protocol cost including all supplies before committing to multi-month research timelines. The difference between a $300 research cycle and a $500 one often determines whether your data remains consistent enough to interpret. Peptide cost alone doesn't predict that.
Understanding how much CJC-1295 no DAC costs in 2026 requires looking past the vial price. Factor in purity verification, cold-chain logistics, reconstitution infrastructure, and structural waste. Then match your sourcing tier to your documentation requirements. Labs publishing results or operating under institutional governance cannot compromise on COA standards regardless of budget pressure. Independent researchers prioritising biological activity over paperwork can access mid-tier pricing without sacrificing peptide quality. The premium isn't better science. It's better compliance. Choose accordingly, store correctly, and your per-protocol investment delivers the data consistency that makes peptide research worthwhile.
Frequently Asked Questions
An 8-week protocol using 100mcg three times weekly costs $70–$140 for peptides alone, requiring 2–4 vials at 2mg each. Add bacteriostatic water ($10), syringes ($6–$12), and alcohol prep supplies ($8) for total per-cycle cost of $94–$170. Labs using daily dosing protocols should budget $180–$280 for peptides as consumption increases to 5.6mg total across 56 doses.
Price variation reflects purity documentation standards, batch testing frequency, and cold-chain logistics quality rather than peptide synthesis cost differences. Budget suppliers ($28–$38 per vial) provide minimal or no third-party COA verification. Mid-tier sources ($45–$65) include HPLC testing every 3–5 batches. Premium suppliers ($70–$90) test every batch with full mass spectrometry and endotoxin screening, required for institutional research and publication-quality work.
Only if the supplier provides verifiable third-party COA documentation showing 97%+ purity via HPLC. Pricing below $30 typically indicates bulk wholesale access, clearance stock nearing expiration, or absence of purity verification. Research facilities operating under IRB oversight or planning to publish findings cannot use peptides without batch-specific certificates of analysis regardless of price.
Both variants cost $35–$85 per 2mg vial at similar purity tiers because synthesis complexity is comparable. The no DAC form’s 30-minute half-life versus 6–8 days for DAC means no DAC protocols consume 3–5× more peptide across equivalent timeframes due to more frequent dosing requirements. The structural difference affects protocol design and total consumption, not per-vial pricing.
Bacteriostatic water adds $10 per 30mL bottle (sufficient for 10–12 reconstitutions), insulin syringes cost $6–$12 per 10-pack, alcohol prep pads run $8 per 100-count box, and cold storage infrastructure ranges from $400–$1,200 for refrigeration and $600–$2,500 for −20°C freezers. Reconstitution and dosing waste typically consumes 5–10% of total peptide volume, requiring one extra vial per 10–12 used.
Yes — orders of 20+ vials access wholesale pricing tiers that reduce per-unit cost to $28–$32, a 30–40% discount versus single-vial purchases. Peptide synthesis exhibits significant economies of scale after 10-gram production runs, allowing suppliers to pass savings to high-volume buyers. Single-vial purchasers pay retail markup that bulk buyers avoid entirely.
Lyophilised CJC-1295 no DAC maintains 95%+ potency for 24 months when stored at −20°C. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28 days — beyond that window, degradation accelerates by 10–15% per additional week. Improper storage during shipping or at-facility handling causes more protocol failures than peptide purity issues, making cold-chain logistics worth the $8–$15 premium per order.
Standard reconstitution uses 2mL bacteriostatic water per 2mg vial, creating a 1mg/mL solution where 10 units (0.1mL) on an insulin syringe delivers 100mcg. A 30mL bottle of bacteriostatic water costs $8–$12 and reconstitutes 10–12 vials depending on waste. Labs using 1mL reconstitution volume double the concentration but increase dosing precision requirements and error magnitude.
Budget tier ($28–$38) claims 95%+ purity without third-party verification. Mid-tier ($45–$65) provides HPLC-verified 97–98% purity with COA documentation. Premium tier ($70–$90) guarantees 98%+ purity with full mass spectrometry, endotoxin screening, and batch-specific traceability. For research requiring publication or institutional compliance, only the latter two tiers meet documentation standards.
Request batch-specific HPLC results showing peptide content quantification, not just a generic COA template. Legitimate suppliers provide this within 24 hours. Verify the testing lab is independent (not in-house) and recognised in peptide analysis. Check that the molecular weight on mass spectrometry results matches CJC-1295 no DAC (3367.97 Da) — generic ‘growth hormone secretagogue’ labels without exact molecular confirmation indicate unverified sourcing.